Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koorosh Korfi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Epigenetics|January 21, 2017
Follicular lymphoma, a B cell malignancy addicted to epigenetic mutationsKoorosh Korfi, Sara Ali, James A Heward, et al.
Expert Review of Molecular Diagnostics|September 21, 2016
Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicineShamzah Araf, Koorosh Korfi, Tahrima Rahim, et al.
Current Opinion in Hematology|May 9, 2018
Precision medicine and lymphomaJames A Heward, Emil A Kumar, Koorosh Korfi, et al.
Computational and Structural Biotechnology Journal|November 26, 2019
Applications and analysis of targeted genomic sequencing in cancer studiesFindlay Bewicke-Copley, Emil Arjun Kumar, Giuseppe Palladino, et al.
Frontiers in Oncology|May 19, 2023
CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemiaLaurène Pousse, Koorosh Korfi, Bruno C Medeiros, et al.
Clinical Pharmacology and Therapeutics|April 18, 2025
Oncology Dose Optimization: Tailored Approaches to Different Molecular ClassesJiawen Zhu, Amy Schroeder, Sabine Frank, et al.
Blood|October 30, 2016
CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expressionAnuradha Tarafdar, Lisa E M Hopcroft, Paolo Gallipoli, et al.
Cancer Discovery|September 16, 2016
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase InhibitionMary T Scott, Koorosh Korfi, Peter Saffrey, et al.
Blood Advances|December 23, 2021
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphomaAnn-Marie E Bröske, Koorosh Korfi, Anton Belousov, et al.
British Journal of Haematology|August 27, 2024
CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Arjun Kumar, Koorosh Korfi, Findlay Bewicke-Copley, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Epigenetics|January 21, 2017
Follicular lymphoma, a B cell malignancy addicted to epigenetic mutationsKoorosh Korfi, Sara Ali, James A Heward, et al.
Expert Review of Molecular Diagnostics|September 21, 2016
Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicineShamzah Araf, Koorosh Korfi, Tahrima Rahim, et al.
Current Opinion in Hematology|May 9, 2018
Precision medicine and lymphomaJames A Heward, Emil A Kumar, Koorosh Korfi, et al.
Computational and Structural Biotechnology Journal|November 26, 2019
Applications and analysis of targeted genomic sequencing in cancer studiesFindlay Bewicke-Copley, Emil Arjun Kumar, Giuseppe Palladino, et al.
Frontiers in Oncology|May 19, 2023
CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemiaLaurène Pousse, Koorosh Korfi, Bruno C Medeiros, et al.
Clinical Pharmacology and Therapeutics|April 18, 2025
Oncology Dose Optimization: Tailored Approaches to Different Molecular ClassesJiawen Zhu, Amy Schroeder, Sabine Frank, et al.
Blood|October 30, 2016
CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expressionAnuradha Tarafdar, Lisa E M Hopcroft, Paolo Gallipoli, et al.
Cancer Discovery|September 16, 2016
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase InhibitionMary T Scott, Koorosh Korfi, Peter Saffrey, et al.
Blood Advances|December 23, 2021
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphomaAnn-Marie E Bröske, Koorosh Korfi, Anton Belousov, et al.
British Journal of Haematology|August 27, 2024
CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Arjun Kumar, Koorosh Korfi, Findlay Bewicke-Copley, et al.
Pageof 2